About FDA

CVM: An OIE Collaborating Center

In May 2011, the CVM became an official OIE Collaborating Center in International Cooperation to Strengthen Veterinary Drug Regulatory Infrastructure. The sphere of competence of this Center is the exchange of information about regulatory legislation and related programs to help assure the availability of safe and effective veterinary drugs. Some recent and ongoing CVM activities that support this designation as a global Center of the OIE include:

  • Serving as an international center of research, scientific expertise, standardization and dissemination of techniques including:
    • Ensuring drug safety and effectiveness
    • Monitoring safety following drug approvals through the Adverse Drug Experience Reports
    • Minimizing and researching antimicrobial resistance and residues
    • US approval of the first Generically Engineered animal
    • Researching effective use of biomarkers for diseases
    • Risk assessment of cloning techniques
  • Harmonization of international surveillance and control of animal diseases
    • Funding for establishment of an Advisory Group on Integrated Surveillance of Antimicrobial Resistance to the World Health Organization
    • Management of the U.S. NARMS program and integration of the World Health Organization – Global Food-Borne Infections Network (WHO-GSS)
  • Provision of expert consultancy, or scientific and technical training for the OIE or OIE Members
    • Participation in the Codex Alimentarius Commission ad hoc Codex Intergovernmental Task Force on Antimicrobial Resistance
    • Participation in the International Cooperation of Harmonization of Technical Requirements for Registration of Veterinary Products (VICH)
    • Other capacity building workshops in various nations including workshops in China, Costa Rica, El Salvador, Argentina, Chile, Brazil, Trinidad and Tobago, Mexico, and Paraguay
  • Active participation in scientific and technical studies in collaboration with other laboratories or organizations
    • National Antimicrobial Resistance Monitoring System
    • DNA Microarray for Characterizing Salmonella genomes
    • Ad hoc Intergovernmental Task Force on Antimicrobial Resistance
  • Developing rapid screening methods for Salmonella enterica serotype Newport

Page Last Updated: 08/25/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.